Medication info
Olmezan 20 mg (Olmesartan Medoxomil)

Olmezan 20 mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201100946 · Approved 2011.02.25 · Insurance code 663604840

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after initiation of treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while carefully monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this medicine to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this medicine have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
<Pediatrics> The safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is a condition characterized by persistently high blood pressure, and this medication lowers blood pressure to reduce the burden on the heart and blood vessels. This helps decrease the risk of serious complications like stroke and myocardial infarction. Patients can benefit from regular medication intake to help control blood pressure. Additionally, enhancing lifestyle habits alongside medication therapy is important. This medication effectively treats essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after initiation of treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while carefully monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this medicine to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this medicine have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

<Pediatrics> The safety and efficacy in pediatric patients have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to any of its ingredients, those who are pregnant or breastfeeding, those undergoing kidney dialysis, those with severe liver dysfunction, or those with bile duct obstruction should not take this medication. Those with hereditary issues like lactose intolerance should also avoid this medication. Patients with decreased blood volume or those taking high-dose diuretics should be cautious as they may experience symptoms of low blood pressure, and appropriate action should be taken immediately if symptoms appear. Patients with decreased kidney function or those who have had a kidney transplant should regularly check kidney function and potassium levels through blood tests, and use is not recommended in cases of severe kidney impairment. Patients with specific heart diseases or hyperkalemia should also take caution when using this medication. Dizziness may occur while taking this medication; thus, it is advisable to avoid hazardous activities such as driving or working at heights. This medication is used for the treatment of hypertension and has been deemed relatively safe in clinical trials, but side effects such as dizziness, headache, and dyspepsia can occur. If unusual symptoms such as chronic diarrhea or abdominal pain arise, consultation with a doctor to discontinue this medication is necessary. Care is needed when taking this medication with potassium-sparing diuretics or potassium supplements, as it may raise serum potassium levels. The blood pressure-lowering effect may increase when combined with other antihypertensive medications. Caution is advised when used with lithium, as it may raise lithium levels and cause toxicity, so concurrent use should be avoided. Taking this medication with non-steroidal anti-inflammatory drugs can increase the risk of worsening kidney function. This medication should be avoided during pregnancy to prevent serious damage to the fetus, and if breastfeeding, it should be discontinued or cessation of breastfeeding should be considered due to potential adverse reactions in infants. Safety in pediatric patients has not yet been established, so use should be approached with caution. Elderly patients may experience slowed drug metabolism, and dose adjustment may be necessary. In cases of overdose, symptoms such as low blood pressure and palpitations may occur, and immediate medical assistance should be sought. This medication is known to have a low risk of carcinogenicity or genotoxicity even with long-term use, but it should be taken according to the physician's instructions.

Side effects

  • Dizziness
  • back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • lightheadedness
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • weakness
  • vascular edema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • increased blood pressure
  • epistaxis
  • asthma
  • epistaxis
  • upper respiratory infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 25 degrees Celsius. This helps maintain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.